Therapeutic and prophylactic ethanol lock therapy in patients with bleeding disorders

Haemophilia

Volumn 20, Issue 1, 2014, Pages 52-57

  Rajpurkar, M ^a,b   Mcgrath, E ^a,b   Joyce, J ^a   Boldt Macdonald, K ^a   Chitlur, M ^a,b   Lusher, J ^a,b  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Bleeding disorders; Catheter related infections; Ethanol lock

Indexed keywords

ALCOHOL; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ARTICLE; BLEEDING; BLEEDING DISORDER; CATHETER INFECTION; CLINICAL ARTICLE; ETHANOL LOCK THERAPY; HUMAN; MALE; PRIORITY JOURNAL;

BLEEDING DISORDERS; CATHETER-RELATED INFECTIONS; ETHANOL LOCK;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BLOOD COAGULATION DISORDERS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; ETHANOL; HUMANS; MALE; TREATMENT OUTCOME;

EID: 84890857334     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12241     Document Type: Article

References (25)

1. Hothi DK, Kelsall W, Baglin T, Williams DM. Bacterial endocarditis in a child with haemophilia B: risks of central venous catheters. Haemophilia 2001; 7: 507-10.
2. Crary SE, Buchanan GR, Journeycake JM. Fatal central venous catheter-related infection in haemophilia. Haemophilia 2006; 12: 183-6.
3. Li CH, Ou Y, Lee AC, So KT. Septic arthritis in hemophilia with central venous catheter: a case report. Pediatr Hematol Oncol 2000; 17: 187-9.
4. Ball PA, Brokenshire E, Parry B et al. Ethanol locking as a possible treatment for microbial contamination of long-term central venous catheters. Nutrition 2003; 19: 570.
5. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol 2003; 25: 616-21.
6. Metcalf SC, Chambers ST, Pithie AD. Use of ethanol locks to prevent recurrent central line sepsis. J Infect 2004; 49: 20-2.
7. Rajpurkar M, Boldt-Macdonald K, McLenon R et al. Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients. Haemophilia 2009; 15: 1267-71.
8. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51: 1-29.
9. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-32.
10. National Hemophilia Foundation. MASAC recommendations Concerning Prophylaxis (Regular administration of Clotting Factor Concentrate to prevent bleeding) 2007. Available at http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=1007. Accessed July 18, 2013.
11. DiMichele DM, Hoots WK, Pipe SW, Rivard GE, Santagostino E. International workshop on immune tolerance induction: consensus recommendations. Haemophilia 2007; 13(Suppl. 1): 1-22.
12. Siboni SM, Zanon E, Sottilotta G et al. Central nervous system bleeding in patients with rare bleeding disorders. Haemophilia 2012; 18: 34-8.
13. Valentino LA, Kawji M, Grygotis M. Venous access in the management of hemophilia. Blood Rev 2011; 25: 11-5.
14. Titapiwatanakun R, Moir C, Pruthi RK, Stavlo PL, Schmidt KA, Rodriguez V. Central venous access devices for paediatric patients with haemophilia: a single-institution experience. Haemophilia 2009; 15: 168-74.
15. Wolf J, Shenep JL, Clifford V, Curtis N, Flynn PM. Ethanol lock therapy in pediatric hematology and oncology. Pediatr Blood Cancer 2013; 60: 18-25.
16. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis 2001; 7: 277-81.
17. Broom JK, Krishnasamy R, Hawley CM, Playford EG, Johnson DW. A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients - the HEALTHY-CATH trial. BMC Nephrol 2012; 13: 146.
18. Flynn PM, Willis B, Gaur AH, Shenep JL. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 2003; 21: 3520-5.
19. Segarra-Newnham M, Martin-Cooper EM. Antibiotic lock technique: a review of the literature. Ann Pharmacother 2005; 39: 311-8.
20. Wales PW, Kosar C, Carricato M, de Silva N, Lang K, Avitzur Y. Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience. J Pediatr Surg 2011; 46: 951-6.
21. Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 2007; 31: 302-5.
22. Bell RL, Rodd-Henricks ZA, Kuc KA et al. Effects of concurrent access to a single concentration or multiple concentrations of ethanol on the intake of ethanol by male and female periadolescent alcohol-preferring (P) rats. Alcohol 2003; 29: 137-48.
23. Crnich CJ, Halfmann JA, Crone WC, Maki DG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol 2005; 26: 708-14.
24. Cober MP, Kovacevich DS, Teitelbaum DH. Ethanol-lock therapy for the prevention of central venous access device infections in pediatric patients with intestinal failure. JPEN Journal of Parenteral and Enteral Nutr 2011; 35: 67-73.
25. Kayton ML, Garmey EG, Ishill NM et al. Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections. J Pediatr Surg 2010; 45: 1961-6.